Company intelligence / Profile preview

MedAccess

London, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

MedAccess is an independent, not-for-profit company established to accelerate access to essential health products in low- and middle-income countries by using innovative finance agreements to reduce prices and increase availability. By the end of 2024, its agreements had secured affordable access to medical innovations for more than 559 million people in over 115 countries, focusing on infectious diseases and now expanding into NCDs.

Therapeutic areas: OtherInfectious Diseases
Industry: Investors

Partnerships

Clinton Health Access Initiative (CHAI)Gates FoundationBritish International Investment (BII)PATHGavi, the Vaccine AllianceOpen Society FoundationsUnitaidUNICEFSD BiosensorWondfoElektadsm-firmenichHologicBASFMacleods Pharmaceuticals

Beyond the preview

Go deeper on MedAccess.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedAccess.

Explore the full profile